MedTrace Logo

The Various Effects of Gaseous Albuterol on Serum Lactate

NCT02073747 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2017-08-14

Study results available
· View outcomes & findings →

Summary

Empirical data from physician observation indicates an increase in serum lactate in acute asthmatic patients being treated with inhaled albuterol therapy.

It is not clear if this increased serum lactate is in response to a physiological response to the asthmatic process or from the albuterol treatment.

This study is designed to determine if administration of inhaled albuterol increases serum lactate in healthy subjects.

Conditions

Interventions

DRUG

Normal Saline

One hour inhaled normal saline

DRUG

Albuterol

One hour inhaled ten milligrams of albuterol

Sponsors & Collaborators

  • University Medical Center of Southern Nevada

    lead OTHER

Principal Investigators

  • Tony Zitek, MD · Emergency Medicine Residency Faculty

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2015-07-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02073747 on ClinicalTrials.gov